Abiopharma

Heier Jeffrey S. 🟢 acquired 320.0K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001284

Praxis Precision Medicines, Inc. Announces Proposed Public Offering

Bulis Veronica Sanchez 🔴 sold 2.1K shares of Lyell Immunopharma, Inc. (LYEL) at $38.67 Transaction Date: Dec 24, 2025 | Filing ID: 000001

📋 NEIL W PETERSON (Officer) plans to sell 5K shares of MERIT MEDICAL SYSTEMS, INC. (at $90.00 each, total $450K) Filed: Jan 06, 2026 | ID: 000166

New Form S-8 - Biomea Fusion, Inc. Filed: 2026-01-06 AccNo: 0001193125-26-004374 Size: 196 KB

New Form POS AM - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001281 Size: 22 KB

(99% Neutral) PMGC Holdings Inc. (ELAB) Files Form 8-K

Notman Donald 🟢 acquired 320.0K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.8M) Transaction Date: Jan 02, 2026 | Filing ID: 001282

(99% Neutral) SPECTRAL AI, INC. (MDAI) Announces Executive Departure

Director Wampler Kira Scherer 🟡 adjusted position in 2.0K shares (3 derivative) of Doximity, Inc. (DOCS) at $44.65 Transaction Date: Jan 02, 2026 | Filing ID: 000003

(99% Neutral) Flora Growth Corp. (FLGC) Announces New Board Appointment

(99% Neutral) Estrella Immunopharma, Inc. (ESLA) Announces Business Combination

Stoke Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

LILLY ENDOWMENT INC 🔴 sold 1.4K shares of ELI LILLY & Co (LLY) at $1,085.01 ($1.5M) Transaction Date: Jan 05, 2026 | Filing ID: 000001

Kiener Peter A 🟢 acquired 24.4K shares (1 derivative) of Cue Biopharma, Inc. (CUE) at $0.34 Transaction Date: Jan 02, 2026 | Filing ID: 004359